Nektar Therapeutics (NKTR)
57.74
-1.04
(-1.77%)
USD |
NASDAQ |
Dec 10, 16:00
57.66
-0.08
(-0.14%)
After-Hours: 20:00
Nektar Therapeutics Profit Margin (Quarterly): -301.3% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 31.72% |
| Amicus Therapeutics, Inc. | 10.24% |
| Regeneron Pharmaceuticals, Inc. | 38.89% |
| Rigel Pharmaceuticals, Inc. | 40.17% |
| Zevra Therapeutics, Inc. | -2.09% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -327.7% |
| Return on Assets | -43.84% |
| Return on Invested Capital | -54.14% |
| Gross Profit Margin (Quarterly) | 98.34% |
| Operating Margin (Quarterly) | -267.4% |
| Return on Net Operating Assets | -628.9% |